Romero-Castro Rafael, Pellicer-Bautista Francisco J, Jimenez-Saenz Manuel, Marcos-Sanchez Francisco, Caunedo-Alvarez Angel, Ortiz-Moyano Carlos, Gomez-Parra Manuel, Herrerias-Gutierrez Juan M
Service of Gastroenterology, Service of Vascular Invasive Radiology, Virgen Macarena Hospital, Seville, Spain.
Gastrointest Endosc. 2007 Aug;66(2):402-7. doi: 10.1016/j.gie.2007.03.008.
Bleeding from gastric varices can be challenging because of its high mortality and recurrent bleeding rates. Endoscopic therapy with tissue adhesives can control acute hemorrhage, but recurrent bleeding could appear if obliteration is not achieved, and endoscopic vision could be troublesome in the case of massive hemorrhage. The glue injected could be responsible for embolic phenomena and local complications. EUS has proved useful in minimizing the risk of recurrent bleeding from gastric varices, accurately showing if they are obturated or not. The presence of perforating veins detected by EUS has been reported as a risk factor for recurrent bleeding from esophageal varices.
To assess the efficacy of EUS-guided cyanoacrylate injection in gastric varices at the entrance of the perforating veins to obtain variceal obturation.
Open-basis case series study.
Tertiary care, academic medical center, Seville, Spain.
Five consecutive patients with gastric varices were enrolled from May 2005 through May 2006.
We injected cyanoacrylate-lipiodol in gastric varices with 22-gauge needles by EUS guidance.
To analyze the obliteration of gastric varices, the recurrent bleeding rate, and safety of EUS-guided cyanoacrylate-lipiodol injection.
EUS-guided injection of the perforating veins by using cyanoacrylate-lipiodol was successful in eradicating gastric varices in the 5 patients treated, without recurrent bleeding or other complications during the study follow-up.
This is a single-center nonrandomized study.
EUS-guided injection of cyanoacrylate at the level of the perforating veins in the treatment of gastric varices seems to be a safe, efficient, and accurate approach. Further controlled studies are warranted.
胃静脉曲张出血因其高死亡率和再出血率而具有挑战性。使用组织粘合剂的内镜治疗可控制急性出血,但如果未实现闭塞,可能会出现再出血,并且在大出血情况下内镜视野可能会受到影响。注射的胶水可能导致栓塞现象和局部并发症。超声内镜已被证明有助于降低胃静脉曲张再出血的风险,能准确显示静脉曲张是否闭塞。据报道,超声内镜检测到的穿支静脉的存在是食管静脉曲张再出血的危险因素。
评估超声内镜引导下在穿支静脉入口处注射氰基丙烯酸酯治疗胃静脉曲张以实现静脉曲张闭塞的疗效。
开放性病例系列研究。
西班牙塞维利亚的三级医疗学术医学中心。
2005年5月至2006年5月连续纳入5例胃静脉曲张患者。
在超声内镜引导下,我们用22号针将氰基丙烯酸酯-碘油注入胃静脉曲张。
分析胃静脉曲张的闭塞情况、再出血率以及超声内镜引导下氰基丙烯酸酯-碘油注射的安全性。
在接受治疗的5例患者中,超声内镜引导下使用氰基丙烯酸酯-碘油注射穿支静脉成功消除了胃静脉曲张,在研究随访期间无再出血或其他并发症。
这是一项单中心非随机研究。
超声内镜引导下在穿支静脉水平注射氰基丙烯酸酯治疗胃静脉曲张似乎是一种安全、有效且准确的方法。有必要进行进一步的对照研究。